Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: Study of Crisaborole Ointment 2% in Mild to Moderate Atopic Dermatitis [Phase 4]
Phase 4 clinical trial update for Crisaborole 2% ointment in mild to moderate atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis [Phase 2]
A Phase 2 trial evaluating ASB17061 capsules in adults with atopic dermatitis has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: Trial on Effectiveness Combined Probiotics in Atopic Dermatitis in Children [Phase 4]
A Phase 4 clinical trial evaluating the effectiveness of combined probiotics in children with atopic dermatitis has been completed.
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndrome [Phase 3]
Phase 3 trial update for OPA-15406 ointment in adults with atopic dermatitis completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 3]
Phase 3 trial of baricitinib in adults with moderate to severe atopic dermatitis has completed; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: Comparison Trial of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis [Phase 3]
Phase 3 trial updating pediatric use of OPA-15406 ointment for atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-19Clinical Trial Update: A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable [Phase 3]
A Phase 3 long-term study evaluating Baricitinib in combination with topical corticosteroids for adults with moderate-to-severe atopic derma…
-
CLINICAL_TRIALS trial_result · 2021-01-19Clinical Trial Update: Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy [Phase 3]
A Phase 3 trial evaluating PF-04965842 and dupilumab for adult moderate-to-severe atopic dermatitis on topical therapy has completed with re…
-
CLINICAL_TRIALS trial_result · 2021-01-14Clinical Trial Update: Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3 [Phase 3]
A Phase 3 study (ECZTRA 3) evaluating tralokinumab in combination with topical corticosteroids for moderate to severe atopic dermatitis has …
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 trial evaluating MOR106 with topical corticosteroids in adults with moderate to severe atopic dermatitis was terminated; results wer…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: 8-Week Atopic Dermatitis (AD) Treatment Study [Phase 3]
Phase 3 clinical trial update for an 8-week atopic dermatitis treatment completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-30Clinical Trial Update: Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch) [Phase 3]
Phase 3 long-term safety study of serlopitant for pruritus was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-11-20Clinical Trial Update: Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1) [Phase 3]
ECZTRA 1 is a Phase 3 trial of tralokinumab monotherapy for moderate-to-severe atopic dermatitis, with results posted after trial completion…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: A Phase I Study of HY209 Gel in Healthy Male Volunteers for Atopic Dermatitis [Phase 1]
Phase I trial of HY209 Gel in healthy volunteers completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema) [Phase 2]
Phase 2 trial update evaluating safety and tolerability of dupilumab in children aged 6 to <18 with atopic dermatitis; results posted after …
-
CLINICAL_TRIALS trial_result · 2020-08-26Clinical Trial Update: Effect of Sublingual Immunotherapy in Patients With Atopic Dermatitis [Phase 4]
A Phase 4 clinical trial evaluating the effect of sublingual immunotherapy in patients with atopic dermatitis has been completed.
-
CLINICAL_TRIALS trial_result · 2020-08-24Clinical Trial Update: Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2) [Phase 3]
ECZTRA 2, a Phase 3 trial of tralokinumab monotherapy for moderate-to-severe atopic dermatitis, has completed with results posted in 2020. T…
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: A Study to Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically Advisable [Phase 3]
Phase 3 trial assessing dupilumab for severe atopic dermatitis not controlled with cyclosporine A. Trial completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic Dermatitis [Phase 4]
Open-label, single-arm longitudinal Phase 4 trial investigating dupilumab for atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2020-08-13Clinical Trial Update: Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD) [Phase 3]
A Phase 3 trial evaluated dupilumab with topical corticosteroids in children 6 to less than 12 years with severe atopic dermatitis; results …
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis [Phase 3]
Phase 3 study of baricitinib plus topical corticosteroids in adults with moderate-to-severe atopic dermatitis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: Clinical Evaluation of Metal Panel Allergens: Dose Response Study [Phase 2]
Phase 2 clinical trial evaluating dose response of metal panel allergens in dermatitis eczema, completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-23Clinical Trial Update: Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis [Phase 2]
Phase 2 study of OPA-15406 ointment in pediatric patients with atopic dermatitis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-16Clinical Trial Update: A Study to Evaluate ABT-494 (Upadacitinib) in Adults With Moderate to Severe Atopic Dermatitis [Phase 2]
A Phase 2 clinical trial evaluating ABT-494 (Upadacitinib) in adults with moderate to severe atopic dermatitis has completed with results po…
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Vitamin D in Egyptian Children With Atopic Dermatitis [Phase 3]
Phase 3 trial update on vitamin D in Egyptian children with atopic dermatitis has completed.